CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,214,769
+54.2%
419,430
+42.3%
0.01%
+50.0%
Q2 2023$13,757,769
+50.9%
294,662
+23.6%
0.00%
+33.3%
Q1 2023$9,119,156
-29.7%
238,347
+0.7%
0.00%
-25.0%
Q4 2022$12,965,516
+78.7%
236,597
+11.1%
0.00%
+33.3%
Q3 2022$7,254,000
+365.6%
213,019
+29.2%
0.00%
+200.0%
Q2 2022$1,558,000
-36.7%
164,823
-5.0%
0.00%0.0%
Q1 2022$2,463,000
-33.2%
173,546
-0.4%
0.00%0.0%
Q4 2021$3,686,000
-0.3%
174,252
+5.4%
0.00%0.0%
Q3 2021$3,696,000
+7.2%
165,353
+19.0%
0.00%0.0%
Q2 2021$3,449,000
+7.0%
138,993
+25.1%
0.00%0.0%
Q1 2021$3,224,000
+15.8%
111,111
+2.9%
0.00%0.0%
Q4 2020$2,785,000
-16.1%
107,932
+0.1%
0.00%
-50.0%
Q3 2020$3,320,000
+161.4%
107,813
+111.6%
0.00%
+100.0%
Q2 2020$1,270,000
+35.1%
50,945
+14.9%
0.00%0.0%
Q1 2020$940,000
+16.9%
44,326
+22.4%
0.00%
Q4 2019$804,000
+9.4%
36,224
+12.2%
0.00%
Q3 2019$735,00032,2890.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders